Portal de Periódicos da CAPES

Zoladex® (goserelin) in the treatment of benign gynaecological disorders: an overview of safety and efficacy

1992; Wiley; Volume: 99; Issue: s7 Linguagem: Inglês

10.1111/j.1471-0528.1992.tb13539.x

1471-0528

R. Matthew Miller, Ronald Frank,

Estrogen and related hormone effects

BJOG: An International Journal of Obstetrics & GynaecologyVolume 99, Issue s7 p. 37-41 Zoladex® (goserelin) in the treatment of benign gynaecological disorders: an overview of safety and efficacy R. M. MILLER, Corresponding Author R. M. MILLER Medical Research Department, ICI Pharmaceuticals, Alderley Park, Macclesfield, UKDr R. Miller, Medical Research Department, ICI Pharmaceuticals, Mereside, Alderley Park, Macclesfield, UK.Search for more papers by this authorR. A. FRANK, R. A. FRANK Medical Research Department, ICI Pharmaceuticals, Alderley Park, Macclesfield, UKSearch for more papers by this author R. M. MILLER, Corresponding Author R. M. MILLER Medical Research Department, ICI Pharmaceuticals, Alderley Park, Macclesfield, UKDr R. Miller, Medical Research Department, ICI Pharmaceuticals, Mereside, Alderley Park, Macclesfield, UK.Search for more papers by this authorR. A. FRANK, R. A. FRANK Medical Research Department, ICI Pharmaceuticals, Alderley Park, Macclesfield, UKSearch for more papers by this author First published: February 1992 https://doi.org/10.1111/j.1471-0528.1992.tb13539.xCitations: 14Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Rock J. A. (1991) A muticenter comparison of GnRH agonist (Zoladex®) and danazol in the treatment of endometriosis. Abstract presented at the 47th Annual Meeting of the American Fertility Society, Orlando , 1991. 2 Van der Spuy Z. M, Fieggan A. G., Wood M. A. & Piennaar C. A. (1989) The short term use of luteinizing hormone releasing hormone analogues in uterine fibroids. Hormon Res 32, 137– 140. 3 Hackenberg R., Gesenhues T., Deichert U., Duda V., Sturm G. & Schulz K. D. (1990) Preoperative reduction of myomas of the uterus by the GnRH-analogue Goserelin (‘Zoladex’). Gehurtshilfe und Frauenheilkunde 50, 136– 139. 4 Gesenhues X, Hackenberg R., Deichert U., Sturm G. & Schulz K. D. (1990) Treatment of uterine fibroids with the GnRH analogue Goserelin. Gynecol Endocrinol 4, 41. 5 Donnez J., Gillerot S., Bourgonjon D., Clerckx F. & Nisolle M. (1990) Neodymium: YAG laser hysteroscopy in large submucous fibroids. Fertil Steril 54, 999– 1003. 6 Candiani G. B., Vercellini P., Fedele L., Arcaini L., Bianchi S. & Candiani M. (1990) Use of Goserelin depot, a gonadotrophin releasing hormone agonist, for the treatment of menorrhagia and severe anaemia in women with leiomyomata uteri. Acta Obstet Gynecol Scand 69, 413– 415. 7 Sagle M., Kiddy D., Mason H. D., Adams J. & Franks S. (1988) Pituitary, ovarian and uterine response to goserelin (‘Zoladex’, ICI) in women with menorrhagia. Gynecol Endocrinol 2, 190. 8 Thomas E., Thomas N. & Okuda K. (1990) The combination of ‘Zoladex’ and cyclical hormone replacement therapy (HRT) successfully treats dysfunctional uterine bleeding. Gynecol Endocrinol 4, 79. 9 Gardner R. & Shaw R. W. (1990) LHRH analogue in the treatment of menorrhagia. Adv Reprod Endocrinol 2, 149– 160. 10 Samra J. S., Obhrai M. S. & Lynch S. (1990) Androgen secretion in polycystic ovarian syndrome (PCOS) results of synacthen stimulation tests pre and post medical oophorectomy using GnRH analogue (‘Zoladex’). Gynecol Endocrinol 4, 71. 11 Nilsson B. S. (1990) Evaluation of methods for recording adverse drug reactions in clinical trials. Eur J Clin Microbiol Infect Dis 9, 534– 536. 12 Kent G. N., Price R. I., Gutteridge D. H. et al. (1990) Human lactation: forearm trabecular bone loss, increased bone turnover, and renal conservation of calcium and inorganic phosphate with recovery of bone mass following weaning. J Bone Mis Res 5, 361– 369. Citing Literature Volume99, Issues7February 1992Pages 37-41 ReferencesRelatedInformation